跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nefrinor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nefrinor
Approved
STANDARD
Nefrinor
Mefar İlaç Sanayii A.Ş.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f12c0a79eb27a37
Company
Mefar İlaç Sanayii A.Ş.
Type
Standard
Approval Details
Approval Id
1f12c0a79eb27a37
Drug Approval Philippines Name
Nefrinor
Product Name
Nefrinor
Registration Number
DR-XY49030
Brand Name
Nefrinor
Generic Name
Norepinephrine (as bitartrate monohydrate)
Dosage Form
Solution for Infusion (I.V.)
Dosage Strength
1 mg/mL (4 mg/4 mL)
Manufacturer
Mefar İlaç Sanayii A.Ş.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
27 March 2024
Expiry Date
27 March 2029
Pharmacologic Category
Adrenergic/Dopaminergic Agent.
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f12c0a79eb27a37
Type
Standard
Back to Philippines FDA Approvals